Pivanex small molecule anti-cancer agent: Began phase II testing

Titan Pharmaceuticals Inc. (TTNP), South San Francisco, Calif. Product: Pivanex small molecule anti-cancer agent Indication: Treat refractory stage III and IV non-small cell lung cancer Status: TTNP b...